Literature DB >> 27515592

Chronic Kidney Disease and Risk for Gastrointestinal Bleeding in the Community: The Atherosclerosis Risk in Communities (ARIC) Study.

Junichi Ishigami1, Morgan E Grams2, Rakhi P Naik3, Josef Coresh1, Kunihiro Matsushita4.   

Abstract

BACKGROUND AND OBJECTIVES: Patients on dialysis are known to have higher risk for gastrointestinal (GI) bleeding. However, data on mild to moderate CKD, particularly elevated albuminuria, are limited. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Among 11,088 participants in the Atherosclerosis Risk in Communities (ARIC) Study, we investigated the association of eGFR and urinary albumin-to-creatinine ratio (ACR) with risk for hospitalization with GI bleeding. Kidney measures were assessed at visit four (1996-1998), and follow-up was continued through 2011.
RESULTS: During a median follow-up of 13.9 years, 686 first incident hospitalizations with GI bleeding were observed (incidence rate, 4.9 per 1000 person-years [95% confidence interval (95% CI), 4.5 to 5.3]). Multivariable Cox proportional hazards models revealed that both lower eGFR and higher ACR were associated with higher risk for GI bleeding. With eGFR≥90 ml/min per 1.73 m2 as a reference, risk for GI bleeding was significant in moderately decreased eGFR of 30-59 ml/min per 1.73 m2 (hazard ratio [HR], 1.51; 95% CI, 1.13 to 2.02), and was highest in severely decreased eGFR<30 ml/min per 1.73 m2 (HR, 7.06; 95% CI, 3.91 to 12.76). Compared with ACR<10 mg/g, risk for GI bleeding became significantly higher in mild albuminuria with ACR 10-29 mg/g (HR, 1.36; 95% CI, 1.08 to 1.69), and was nearly double in moderate and severe albuminuria (HR, 2.13; 95% CI, 1.66 to 2.71 for ACR 30-299 mg/g, and HR, 2.07; 95% CI, 1.33 to 3.22 for ACR≥300 mg/g). These results were largely consistent in demographic and clinical subgroups and independent of incident cardiovascular events or dialysis during follow-up.
CONCLUSIONS: Individuals with even mild to moderate CKD warrant clinical attention regarding the risk of hospitalization with GI bleeding.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  Albumins; Atherosclerosis; Attention; Follow-Up Studies; Humans; Incidence; Proportional Hazards Models; Renal Insufficiency, Chronic; Risk; albuminuria; chronic kidney disease; chronic kidney failure; chronic renal failure; creatinine; gastrointestinal complications; glomerular filtration rate; hospitalization; kidney; proteinuria; renal dialysis

Mesh:

Substances:

Year:  2016        PMID: 27515592      PMCID: PMC5053788          DOI: 10.2215/CJN.02170216

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  45 in total

1.  Prevalence and associations for abnormal bleeding times in patients with renal insufficiency.

Authors:  Ha Yeon Kim; Chan Young Oak; Min Jee Kim; Chang Seong Kim; Joon Seok Choi; Eun Hui Bae; Seong Kwon Ma; Soo Wan Kim
Journal:  Platelets       Date:  2012-05-30       Impact factor: 3.862

2.  Evaluating the yield of medical tests.

Authors:  F E Harrell; R M Califf; D B Pryor; K L Lee; R A Rosati
Journal:  JAMA       Date:  1982-05-14       Impact factor: 56.272

3.  Incidence of bleeding from gastroduodenal ulcers in patients with end-stage renal disease receiving hemodialysis.

Authors:  Jiing-Chyuan Luo; Hsin-Bang Leu; Kuang-Wei Huang; Chin-Chou Huang; Ming-Chih Hou; Han-Chieh Lin; Fa-Yauh Lee; Shou-Dong Lee
Journal:  CMAJ       Date:  2011-11-14       Impact factor: 8.262

4.  Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate.

Authors:  Josef Coresh; Brad C Astor; Geraldine McQuillan; John Kusek; Tom Greene; Frederick Van Lente; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2002-05       Impact factor: 8.860

5.  Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPS.

Authors:  Manish M Sood; Maria Larkina; Jyothi R Thumma; Francesca Tentori; Brenda W Gillespie; Shunichi Fukuhara; David C Mendelssohn; Kevin Chan; Patricia de Sequera; Paul Komenda; Claudio Rigatto; Bruce M Robinson
Journal:  Kidney Int       Date:  2013-05-15       Impact factor: 10.612

6.  Incremental value of upper endoscopy for triage of patients with acute non-variceal upper-GI hemorrhage.

Authors:  Ian M Gralnek; Gareth S Dulai
Journal:  Gastrointest Endosc       Date:  2004-07       Impact factor: 9.427

7.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

8.  Race/Ethnic differences in the risk of hemorrhagic complications among patients with ischemic stroke receiving thrombolytic therapy.

Authors:  Rajendra H Mehta; Margueritte Cox; Eric E Smith; Ying Xian; Deepak L Bhatt; Gregg C Fonarow; Eric D Peterson
Journal:  Stroke       Date:  2014-06-24       Impact factor: 7.914

9.  Impaired function of platelet membrane glycoprotein IIb-IIIa in end-stage renal disease.

Authors:  M P Gawaz; G Dobos; M Späth; P Schollmeyer; H J Gurland; S K Mujais
Journal:  J Am Soc Nephrol       Date:  1994-07       Impact factor: 10.121

10.  Lower gastrointestinal bleeding in chronic hemodialysis patients.

Authors:  Fahad Saeed; Nikhil Agrawal; Eugene Greenberg; Jean L Holley
Journal:  Int J Nephrol       Date:  2011-10-05
View more
  17 in total

1.  Efficacy and safety of more potent antiplatelet therapy with vorapaxar in patients with impaired renal function.

Authors:  Simon Correa; Marc P Bonaca; Benjamin M Scirica; Sabina A Murphy; Erica L Goodrich; David A Morrow; Michelle L O'Donoghue
Journal:  J Thromb Thrombolysis       Date:  2019-04       Impact factor: 2.300

2.  Associations of High-Sensitivity Cardiac Troponin and Natriuretic Peptide With Subsequent Risk of Infection in Persons Without Cardiovascular Disease: The Atherosclerosis Risk in Communities Study.

Authors:  Junichi Ishigami; Ron C Hoogeveen; Christie M Ballantyne; Aaron R Folsom; Josef Coresh; Elizabeth Selvin; Kunihiro Matsushita
Journal:  Am J Epidemiol       Date:  2019-12-31       Impact factor: 4.897

3.  Can NSAIDs Be Used Safely for Analgesia in Patients with CKD?: CON.

Authors:  Bruce Guthrie
Journal:  Kidney360       Date:  2020-09-23

Review 4.  Prevention and Treatment of Bleeding with Direct Oral Anticoagulants.

Authors:  R Monroe Crawley; Rachel L Anderson
Journal:  Drugs       Date:  2020-09       Impact factor: 9.546

5.  Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease.

Authors:  Alexander T Cohen; Janvi Sah; Amol D Dhamane; Theodore Lee; Lisa Rosenblatt; Patrick Hlavacek; Birol Emir; Rachel Delinger; Huseyin Yuce; Xuemei Luo
Journal:  Thromb Haemost       Date:  2021-12-28       Impact factor: 6.681

6.  Impact of the timing of capsule endoscopy in overt obscure gastrointestinal bleeding on yield and rebleeding rate - is sooner than 14 d advisable?

Authors:  Catarina Gomes; Rolando Pinho; Adélia Rodrigues; Ana Ponte; Joana Silva; Jaime Pereira Rodrigues; Mafalda Sousa; João Carlos Silva; João Carvalho
Journal:  World J Gastrointest Endosc       Date:  2018-04-16

7.  Clinical Characteristics and Risk Factors for Rebleeding in Patients with Obscure Gastrointestinal Bleeding.

Authors:  Yuki Baba; Seiji Kawano; Yoshiyasu Kono; Toshihiro Inokuchi; Hiromitsu Kanzaki; Masaya Iwamuro; Keita Harada; Sakiko Hiraoka; Yoshiro Kawahara; Hiroyuki Okada
Journal:  Intern Med       Date:  2020-02-05       Impact factor: 1.271

8.  Chronic kidney disease and cause-specific hospitalisation: a matched cohort study using primary and secondary care patient data.

Authors:  Masao Iwagami; Ben Caplin; Liam Smeeth; Laurie A Tomlinson; Dorothea Nitsch
Journal:  Br J Gen Pract       Date:  2018-07-16       Impact factor: 5.386

9.  Cardiac Biomarkers and Subsequent Risk of Hospitalization With Bleeding in the Community: Atherosclerosis Risk in Communities Study.

Authors:  Lena Mathews; Junichi Ishigami; Ning Ding; Ron C Hoogeveen; Anna Kucharska-Newton; Christie M Ballantyne; Rebecca Gottesman; Elizabeth Selvin; Kunihiro Matsushita
Journal:  J Am Heart Assoc       Date:  2020-03-02       Impact factor: 5.501

10.  Practical issues in clinical scenarios involving CKD patients requiring antithrombotic therapy in light of the 2017 ESC guideline recommendations.

Authors:  Adrian Covic; Simonetta Genovesi; Patrick Rossignol; Philip A Kalra; Alberto Ortiz; Maciej Banach; Alexandru Burlacu
Journal:  BMC Med       Date:  2018-09-19       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.